Advanced Medical Solutions Group
AMS · AIM · Health Care · mcap £614m · 282.0p
Answered by AI only from AMS’s own announcements, every statement linked to its source. Free with an account – no password, just a link. Not investment advice.
- Market cap
- £623m
- EV
- £684m
- Net debt
- £60.3m
- Revenue
- £234m
- Adj. EBITDA
- £51.7m
- Shares
- 220.8m +0.6%
| FY25 | Latest | |
|---|---|---|
| Shares m | 219.5 | 220.8 |
| Change | +0.6% |
Count in force at each financial year end (excl. treasury shares), from the company's voting rights notices or its results. Red: dilution above 5% a year; green: share count falling. * adjusted for a consolidation or split.
-
13 Oct
Publication of Financing Materials
Fuller announced that they had reached agreement on the terms of a recommended cash acquisition pursuant to which the entire issued and to be issued share capital of AMS would...
-
6 Oct
Publication of Financing Materials.
Fuller announced that they had reached agreement on the terms of a recommended cash acquisition pursuant to which the entire issued and to be issued share capital of AMS would...
-
30 Sep
Publication of Financing Materials
Fuller announced that they had reached agreement on the terms of a recommended cash acquisition pursuant to which the entire issued and to be issued share capital of AMS would...
-
16 Sep
Half-year Results
Interim results for the six months ended 30 June 2026
-
1 Sep
Rule 26 Disclosure
ADVANCED MEDICAL SOLUTIONS GROUP PLC ("AMS" or the "Company")
Company filings. Not investment advice.